LUMYKRAS

Sotorasib

Medicamento com Advertência na Gravidez

Medicamento com Advertência no Aleitamento

Medicamento com Advertência na Condução

Medicamento Sujeito a Receita Médica(MSRM)

Medicamento Novo

Medicamento Sujeito a Monitorização Adicional

Clique para ver o Resumo de Grupo deste Medicamento: LUMYKRAS

O RESPONSÁVEL NÃO FORNECEU MAIS INFORMAÇÃO

CONSULTE AS SEGUINTES ALTERNATIVAS:

Resumo de Grupo do LUMYKRAS

16) MEDICAMENTOS ANTINEOPLÁSICOS E IMUNOMODULADORES; 1) CITOTÓXICOS; 9) Outros citotóxicos

SIMILARES QUÍMICOS DO LUMYKRAS (Sotorasib)

Similares Químicos?

Produtos com a mesma molécula e do mesmo Grupo Terapêutico.

Não disponível

SIMILARES TERAPÊUTICOS DO LUMYKRAS

Similares Terapêuticos?

Produtos do mesmo Grupo Terapêutico.

Ácido 5-aminolevulínico

	Ø GLIOLAN	PHOTONAMIC
	1 fr. pó p/sol. oral 1,5 g ‐[0%], [ PVP €0.00 ]

Alpelisib

	Ø PIQRAY	NOVARTIS EUROPHARM
	56 comp. rev. p/pel. (50 mg) + (200 mg) ‐[0%], [ PVP €0.00 ]
	28 comp. rev. p/pel. 200 mg ‐[0%], [ PVP €0.00 ]

Aminolevulinato de metilo

	Ø METVIX	GALDERMA
	1 bis. 2 g cr. (160 mg/g) ‐[0%], [ PVP €0.00 ]

Axicabtagene ciloleucel

	Ø YESCARTA	KITE PHARMA
	1 saco 68 ml dispers. p/perf. 0.4 - 2 x10e8 células ‐[0%], [ PVP €0.00 ]

Bexaroteno

	Ø TARGRETIN	EISAI
	100 cáps. moles 75 mg ‐[0%], [ PVP €931.72 ]

Bortezomib

	Ø ¥ BORTEZOMIB ACCORD	ACCORD
	1 fr. p/inj. pó p/sol inj. 3,5 mg ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. 1,4 ml sol. inj. 2.5 mg/ml ‐[0%], [ PVP €0.00 ]

	Ø ¥ BORTEZOMIB BAXTER	BAXTER HOLDING
	1 fr. p/inj. pó p/sol. inj. 3,5 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ BORTEZOMIB FRESENIUS KABI	FRESENIUS KABI DEUTSCHLAND
	1 fr. p/inj. pó p/sol. inj. 2,5 mg ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. pó p/sol. inj. 3,5 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ BORTEZOMIB GENERIS	EUGIA PHARMA
	1 fr. p/inj. pó p/sol. inj. 3,5 MG ‐[0%], [ PVP €0.00 ]

	Ø ¥ BORTEZOMIB HIKMA	HIKMA
	1 fr. p/inj. pó p/sol. inj. (3.5 mg) ‐[0%], [ PVP €0.00 ]

	Ø ¥ BORTEZOMIB MYLAN	VIATRIS
	1 fr. p/inj. pó p/sol. inj. 3.5 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ BORTEZOMIB REDDY	REDDY HOLDING
	1 fr. p/ inj. pó p/sol. inj. 3,5 mg ‐[0%], [ PVP €0.00 ]

	Ø BORTEZOMIB STADA	STADA
	1 fr. p/inj. 1,4 ml sol. inj. 2.5 mg/ml ‐[0%], [ PVP €0.00 ]

	Ø ¥ BORTEZOMIB TECNIGEN	FARMOZ
	1 fr. p/inj. 3,5 mg pó p/sol. inj. 3,5 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ BORTEZOMIB VENUS PHARMA	THRIVE PHARMA
	1 fr. p/inj. pó p/sol. inj. 3,5 mg ‐[0%], [ PVP €0.00 ]

Carfilzomib

	Ø KYPROLIS	AMGEN
	1 fr. p/inj. pó p/sol. p/perf. 60 mg ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. pó p/sol. p/perf. 10 mg ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. pó p/sol. p/perf. 30 mg ‐[0%], [ PVP €0.00 ]

Crisantaspase (Asparaginase)

	Ø ¥ ERWINASE [MG]	PORTON BIOPHARMA
	5 frs. p/inj. pó p/sol. inj. ou p/perf. 10000 U.I. ‐[0%], [ PVP €0.00 ]

Dicloreto de rádio (223Ra)

	Ø XOFIGO	BAYER AG
	1 fr. p/inj. 6 ml sol. inj. (1.100 kBq/ml) ‐[0%], [ PVP €0.00 ]

Dostarlimab

	Ø JEMPERLI	GLAXOSMITHKLINE IRELAND
	1 fr. p/inj. 10 ml conc. p/sol. p/perf. 50 mg/ml ‐[0%], [ PVP €0.00 ]

Enfortumab vedotina

	Ø PADCEV	ASTELLAS PHARMA EUROPE
	1 fr. p/inj. 2,3 ml pó p/conc. p/sol. p/perf. 20 mg ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. 3,3 ml pó p/conc. p/sol. p/perf. 30 mg ‐[0%], [ PVP €0.00 ]

Epcoritamab

	Ø TEPKINLY	ABBVIE DEUTSCHLAND
	1 fr. p/inj. 0,8 ml conc. p/sol. inj. (4 mg/0.8 ml) ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. 0,8 ml sol. inj. (48 mg/0.8 ml) ‐[0%], [ PVP €0.00 ]

Eribulina

	Ø ¥ ERIBULINA BAXTER	BAXTER HOLDING
	1 fr. p/inj. 2 ml sol. inj. (0.44 mg/ml) ‐[0%], [ PVP €0.00 ]

	Ø HALAVEN	EISAI
	6 frs. p/inj. 2 ml sol. inj. (0,44 mg/ml) ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. 2 ml sol. inj. (0,44 mg/ml) ‐[0%], [ PVP €0.00 ]

Erlotinib

	Ø ¥ ERLOTINIB MYLAN	VIATRIS
	30 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ]
	30 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ]
	30 comp. rev. p/pel. 25 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ ERLOTINIB QRITOU	TEVA B.V.
	30 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ]
	30 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ]
	30 comp. rev. p/pel. 25 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ ERLOTINIB SANDOZ	SANDOZ
	30 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ]
	30 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ]
	30 comp. rev. p/pel. 25 mg ‐[0%], [ PVP €0.00 ]

	Ø TARCEVA	CHEPLAPHARM REGISTRATION
	30 comp. rev. p/pelíc. 100 mg ‐[0%], [ PVP €0.00 ]

Glofitamab

	Ø COLUMVI	ROCHE REGISTRATION
	1 fr. p/inj. 10 ml conc. p/sol. p/perf. 10 mg/10 ml ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. 2,5 ml conc. p/sol. p/perf. (2,5 mg/2,5 ml) ‐[0%], [ PVP €0.00 ]

Hidroxicarbamida

	Ø ¥ HIDROXICARBAMIDA HIKMA	HIKMA
	100 cáps. 500 mg ‐[0%], [ PVP €0.00 ]

	Ø HYDROXYUREA MEDAC	MEDAC
	100 cáps. 500 mg ‐[0%], [ PVP €0.00 ]

	Ø SIKLOS	THERAVIA
	60 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €104.46 ]

Idelalisib

	Ø ZYDELIG	GILEAD
	60 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ]
	60 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ]

Ixazomib

	Ø NINLARO	TAKEDA PHARMA
	3 cáps. 2,3 mg ‐[0%], [ PVP €0.00 ]
	3 cáps. 3 mg ‐[0%], [ PVP €0.00 ]
	3 cáps. 4 mg ‐[0%], [ PVP €0.00 ]

Lutécio (177Lu) vipivotido tetraxetano

	Ø PLUVICTO	NOVARTIS EUROPHARM
	1 fr. p/inj. 7,5 ml sol. inj. ou p/perf. 1000 MBq/ml ‐[0%], [ PVP €0.00 ]

Mitotano

	Ø LYSODREN	HRA PHARMA
	100 comp. 500 mg ‐[0%], [ PVP €0.00 ]

Niraparib

	Ø ZEJULA Comprimidos	GLAXOSMITHKLINE IRELAND
	56 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ]
	56 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ]

Olaparib

	Ø LYNPARZA Comprimidos	ASTRAZENECA AB
	56 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ]
	56 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ]

Oxodotreótido de lutécio (177Lu)

	Ø LUTATHERA	ADVANCED ACCELERATOR
	1 fr. p/inj. sol. p/perf. (370 MBq/ml) ‐[0%], [ PVP €0.00 ]

Pegaspargase

	Ø ONCASPAR Pó para solução injetável ou para perfusão	SERVIER
	1 fr. p/inj. pó p/sol. inj. ou p/perf. 3750 U ‐[0%], [ PVP €0.00 ]

Ramucirumab

	Ø CYRAMZA	ELI LILLY NEDERLAND
	1 fr. 50 ml conc. p/sol. p/perf. 10 mg/ml ‐[0%], [ PVP €0.00 ]
	1 fr. 10 ml conc. p/sol. p/perf. 10 mg/ml ‐[0%], [ PVP €0.00 ]

Sorafenib

	Ø NEXAVAR	BAYER AG
	112 comp. rev. p/pelíc. 200 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ SORAFENIB ACCORD	ACCORD
	112 comp. rev. p/pel. em dose unitária 200 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ SORAFENIB STADA	STADA
	112 comp. rev. p/pel. 200 mg ‐[0%], [ PVP €0.00 ]

	Ø ¥ SORAFENIB TEVA	TEVA PHARMA
	112 comp. rev. p/pel. 200 mg ‐[0%], [ PVP €0.00 ]

Talazoparib

	Ø TALZENNA	PFIZER EUROPE
	30 cáps. 0.25 mg ‐[0%], [ PVP €0.00 ]
	30 cáps. 1 mg ‐[0%], [ PVP €0.00 ]

Talquetamab

	TALVEY	JANSSEN-CILAG
	1 fr. p/inj. 1,5 ml sol. inj. 2 mg/ml ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. 1 ml sol. inj. 40 mg/ml ‐[0%], [ PVP €0.00 ]

Teclistamab

	Ø TECVAYLI	JANSSEN-CILAG
	1 fr. p/inj. sol inj. 10 mg/ml ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. sol inj. 90 mg/ml ‐[0%], [ PVP €0.00 ]

Trabectedina

	Ø ¥ TRABECTEDINA TEVA	TEVA B.V.
	1 fr. p/inj. pó p/conc. p/sol. p/perf. 0,25 mg ‐[0%], [ PVP €0.00 ]
	1 fr. p/inj. pó p/conc. p/sol. p/perf. 1 mg ‐[0%], [ PVP €0.00 ]

	Ø YONDELIS	PHARMA MAR
	1 fr. pó p/conc. p/sol. p/perf. 0,25 mg ‐[0%], [ PVP €0.00 ]
	1 fr. pó p/conc. p/sol. p/perf. 1 mg ‐[0%], [ PVP €0.00 ]

Tremelimumab

	Ø IMJUDO	ASTRAZENECA AB
	1 fr. 15 ml conc. p/sol. p/perf. (20 mg/ml) ‐[0%], [ PVP €0.00 ]

Tretinoína (ou Ácido retinóico)

	Ø VESANOID	CHEPLAPHARM ARZNEIMITTEL
	100 cáps. moles 10 mg ‐[0%], [ PVP €0.00 ]

Trióxido de arsénio

	Ø ¥ TRIÓXIDO DE ARSÉNIO GENERIS	EUGIA PHARMA
	10 amp. 10 ml conc. p/sol. p/perf. ( mg/ml) ‐[0%], [ PVP €0.00 ]

Venetoclax

	Ø VENCLYXTO	ABBVIE DEUTSCHLAND
	14 comp. rev. p/pel. 10 mg ‐[0%], [ PVP €0.00 ]
	7 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ]
	7 comp. rev. p/pel. 50 mg ‐[0%], [ PVP €0.00 ]

Vismodegib

	Ø ERIVEDGE	ROCHE REGISTRATION
	28 cáps. 150 mg ‐[0%], [ PVP €0.00 ]